Delivery Order SPE2DB20D1050-SPE2DB25FH83D
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,329.50 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 18, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of VIBERZI 100 mg tablets (60-count). This $2,482.04 firm fixed-price delivery order represents a non-set-aside, competitively awarded contract with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of VIBERZI 100 MG tablets (60-count units) valued at $1,138.42 under a firm fixed-price contract. This award, which carries an ultimate completion date of August 8, 2025, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,645.78, is for the delivery of VIBERZI 75 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 29, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide VIBERZI 100 MG TABLET 60S. The contract, valued at $1,337.04, has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp is the prime contractor and this delivery order is issued under a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp valued at up to...
- This $1,650.57 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,483,626 tablets of the medication VIBERZI 100 MG. The order has an ultimate completion date of August 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Viberzi 75 mg tablets (60-count units) with a ceiling value of $2,002.01. This is a firm fixed-price delivery order with an ultimate completion date of August 8, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIBERZI 75 MG TABLET 60S. The firm-fixed-price contract has a ceiling value of $1,707.63 and a completion date of July 10, 2025. It is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a $1,764.27 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of VIBERZI 75 MG TABLET 60S, a pharmaceutical product, with a completion date of May 29, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order, worth $1,650.57, is for the supply of VIBERZI 100 MG TABLET 60S, a medication used to treat irritable bowel syndrome with diarrhea. The contract has a firm fixed price and is set to be completed by March 24, 2023. The place of performance is Conshohocken, PA. This delivery...
- SPE2DB20D1050Indefinite Delivery Contract
- SPE2DB20D1050-SPE2DB25FH83DDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of VIBERZI 75 mg tablets (60-count units) valued at $3,019.24. This is a firm fixed price delivery order with no set-aside designation, issued as a competitive award. The contract is set to be completed by August 12, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. VIBERZI (vibegron) is a prescription medication used to treat overactive bladder, reflecting the breadth of pharmaceutical products that AmerisourceBergen supplies through its federal contracts. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying medications, vaccines, and medical supplies to support military healthcare programs and other government healthcare systems worldwide. The company's substantial IDC vehicle enables flexible fulfillment of diverse pharmaceutical needs across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 8/11/25 |